About Rmark Bio
Rmark Bio is a Healthcare company based in Chicago (United States) founded in 2015, and was acquired by Within3 in April 2021. Recommendation and management platform to help pharmaceutical companies discover academic partners. It operates in the Healthcare and Technology sectors. Rmark Bio has raised $6.04 million across 5 funding rounds from investors including Within3, Lincoln Park Capital and M25. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Sales & Marketing and Life Sciences. Its competitors include IMS Health, Axtria and IntegriChain; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2015 and based in Chicago, United States, rMark Bio operates in the biotech sector by providing a platform that analyzes academic research activities. Data from publications, grants, and websites is processed using natural language processing to generate rMark scores and ranked partner lists. Connections are managed via the Advisor tablet application, which includes search functions, dashboards, alerts, and custom keyword-based reports.
- Headquarters Chicago, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Website rmarkbio.com
- Social LinkedIn X Facebook
- Acquired by Within3 (Apr 2021)
Funding Insights of Rmark Bio
Rmark Bio has successfully raised a total of $6.04M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $2.77 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.04M
- Total Rounds 5
- Last Round Seed — $2.77M
- Investors Count 4
All 5 funding rounds of Rmark Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $2.77M | Seed | – | – | – |
| Feb 2019 | $1.5M | Seed | – | Lincoln Park Capital | |
| Jan 2018 | Debt – Conventional | – | – | – | |
| Jan 2018 | $1.77M | Seed | – | – | – |
| Jun 2015 | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in Rmark Bio
Rmark Bio has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Within3, Lincoln Park Capital and M25.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward North American opportunities. | lpcfunds.com | Chicago, United States | ||
Early-stage venture capital investments are made in Midwest startups. | 2015 | m25vc.com | Chicago, United States | |
Early-stage investments are provided to visionary SaaS founders. | saasventurecapital.com | |||
Early-stage tech startups are invested in across US and Canada. | mathventurepartners.com | Chicago, United States | ||
Digital collaboration platform for health and life sciences is offered. | 2006 | within3.com | Cleveland, United States |
Investor details for Rmark Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Rmark Bio
4 dated milestones of Rmark Bio across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Rmark Bio is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $2.8M.
- Exit Acquired by Within3.
Competitors of Rmark Bio
Rmark Bio has 3 listed competitors in our database, 2 of them funded. They include IMS Health, Axtria and IntegriChain.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imshealth.com | 1954 | Danbury, United States | 17,574 | SaaS and AI-based market intelligence is provided for healthcare companies. | ||
| axtria.com | 2009 | Berkeley Heights, United States | $198.74M | 749 | Data analytics and AI solutions are provided for life sciences. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. |
Detailed competitors of Rmark Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Rmark Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rmark Bio
Complete news archive for Rmark Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rmark Bio
Rmark Bio was founded in 2015.
Rmark Bio is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Rmark Bio is a funded company, having raised a total of $6.04M across 5 funding rounds to date.
Founded in 2015 and based in Chicago, United States, rMark Bio operates in the biotech sector by providing a platform that analyzes academic research activities. Data from publications, grants, and websites is processed using natural language processing to generate rMark scores and ranked partner lists. Connections are managed via the Advisor tablet application, which includes search functions, dashboards, alerts, and custom keyword-based reports.
Rmark Bio's top competitors include Axtria, IntegriChain and IMS Health.
Rmark Bio has 5 investors. Key investors include Within3, Lincoln Park Capital, M25, SaaS Ventures, and MATH Venture Partners.
Yes. Rmark Bio was acquired by Within3 in April 2021.